-
Data were collected from the 2016–2017 National Nutrition and Health Surveillance of Children and Lactating Women, a large-scale cross-sectional survey. Three provinces in eastern China including Hebei Province in the north, Guangxi Province in the south, and Zhejiang Province on the east coast were selected. Postpartum women were sampled[17,18]. The inclusion criteria were as follows: i) breastfeeding after this delivery, ii) no chronic diseases, and iii) no thyroid disease or use of thyroid drugs. Participants were selected using a multi-stage stratified cluster randomization sampling method. The national sample size was calculated based on the rate of anemia in lactating mothers in 2013. The formula is as follows:
$$ N=\frac{u^{2} p\;(1-p)}{(r \times p)^{2}} \times {deff} $$ (1) N, number of samples; deff (design effect) = 2.0; p (anemia rate) = 9.3%; r (relative standard error) = 11%; confidence level (bilateral, CI) = 95%; u = 1.96. There were four types of areas (large cities, small cities, ordinary rural areas, and poor rural areas) in each province, and the non-response rate was 10%. The sample size was approximately 27,500 (covering 275 districts and counties). Moreover, according to the proportion (32.9%) of UIC < 100 µg/L among lactating women in Guangxi, the calculated sample size was 314[6]. A total of 100 participants from each district or county were included. Four types of areas were selected from each district and county. At least 25 mothers were randomly selected from each area. Finally, 1,500 mothers were included in the three provinces (containing five districts or counties in each province with non-high water iodine). In this study, the area types were divided into urban (including large and small cities) and rural (including ordinary and poor rural areas). Participants with missing BMI, UIC, thyroid-stimulating hormone (TSH) level, VA, or VD measurements were excluded. Participants with other missing pertinent covariates (such as age and region) were excluded. Data from 1,311 participants were included in the analysis. Written informed consent was obtained from all the participants. This study was approved by the Ethical Review Committee of the Chinese Centre for Disease Control and Prevention (No. 201614, 3 June 2016), and all documentation and procedures complied with the ethical standards of the committee.
-
Inquiry surveys, anthropometric measurements, and blood and urine sample collection were performed intensively in the community or village at the time of delivery.
Height (cm) and weight (kg) were measured directly by trained interviewers who followed standard protocols similar to the National Health and Nutrition Examination Survey (NHANES) protocol. Height and weight were measured to the nearest 0.1 cm and 0.1 kg respectively without shoes and wearing light clothing only. The BMI was calculated as kilograms divided by height in square meters (kg/m2).
Blood and urine samples were analyzed in laboratories at the provincial level. All laboratories had to pass the National Reference Laboratory examination of the Chinese Center for Disease Control and Prevention. A random spot midstream urine sample was collected in the morning between 08:30 and 12:00 (approximately 8−10 mL) from all participants. After collection, the urine samples were stored in polyethylene plastic tubes and sealed tightly to prevent evaporation. Samples should avoid contact with iodized articles during transportation and be stored at −20 °C until analysis. The UIC was measured using arsenic and cerium catalysis spectrophotometry after digestion in ammonium sulfate solution (WS/T 107.1-2016). Blood samples (6 mL) were collected from the cubital veins of the mothers and stored in gel vacuum tubes. Blood samples were centrifuged at 3,000 rpm for 10 min at room temperature as soon as possible. Serum was stored in a frozen plastic tube made of 99.9% biological-grade polypropylene. If not tested immediately, the serum samples were subsequently frozen at −80 °C until analysis. TSH levels were determined using an automated chemiluminescence immunoassay analyzer (Roche, Germany). High-performance liquid chromatography was used to determine serum VA (retinol) concentration (WS/T 553-2017). The VD [25(OH)D] levels were determined using liquid chromatography-mass spectrometry (WS/T 677-2020).
All the reference ranges of the included parameters are shown in Table 1.
Table 1. Reference range of related parameters
Parameter Reference range Identification BMI (kg/m2)[19,20] < 18.5
18.5 to < 24
24.0 to < 28
≥ 28Underweight
Normal weight
Overweight
ObeseMUIC (μg/L)[21,22] 100−299 and proportion of < 50 was ≤ 20% Adequate iodine intake TSH (mIU/L, Roche Kit) < 0.27 Subclinical hyperthyroidism or hyperthyroidism 0.27 to < 4.20 Normal ≥ 4.20 Subclinical hypothyroidism or hypothyroidism VA (µg/mL) < 0.2
0.2 to < 0.3
≥ 0.3Deficiency
Marginal deficiency
SufficiencyVD (nmol/L) < 30
30 to < 50
≥ 50Deficiency
Insufficiency
SufficiencyNote. MUIC: median urinary iodine concentration, TSH: thyroid-stimulating hormone, BMI: body mass index, VA: vitamin A, VD: vitamin D. -
Data processing and statistical analyses were performed using the IBM SPSS Statistics 23 software. The Kolmogorov–Smirnov (KS) test was used for normality testing. If the indicator was not normally distributed, it was expressed as the median and P25−P75. 95% confidence interval (CI) of UIC was also used to test whether a statistical difference existed between the relevant cut-off point (100 μg/L) and the MUIC, just as the 2018 Guidance on the Monitoring of Salt Iodization Programmes and Determination of Population Iodine Status recommended[21]. Nonparametric statistical tests were used to compare age, BMI, UIC, TSH, VA, and VD among the groups (region, area type, lactation, age, BMI, VA, and VD groups). A two-way ANOVA was performed to analyze the interaction effect. Chi-square tests were used to compare differences in categorical variables. A generalized linear model of the relationship between the UIC and possible factors (including VA and VD) was established. Potential confounders, including region, area type, parity, lactation, age (continuous), and BMI (continuous), were introduced as covariates in the adjusted models. Data were considered statistically significant at P < 0.05.
-
The participants’ characteristics are presented in Table 2. The median age and BMI of the participants were 30.04 (P25−P75: 27.15−34.23) years and 22.78 (P25−P75: 20.65−25.41) kg/m2, respectively. The median UIC, TSH, VA, and VD were 142.00 (P25−P75: 99.10−209.40) μg/L, 1.89 (P25−P75: 1.32−2.59) mIU/L, 0.44 (P25−P75: 0.36−0.53) μg/mL, and 24.04 (P25−P75: 18.20−29.00) ng/mL, respectively. The BMI in Hebei was higher than that in the other two provinces (P < 0.05). More than half of the mothers had two children, and 68.34% were still breastfeeding at that time. The MUICs of the total population and the different provinces were all within the normal range. UIC (median: 166.10, P25−P75: 116.25−228.95, μg/L) and TSH (median: 2.11, P25−P75: 1.48–2.87, mIU/L) in Hebei were the highest (P < 0.05), while 25(OH)D (median: 17.20, P25−P75: 13.70−21.82, ng/mL) levels was the lowest (P < 0.05), with an average level less than 20 ng/mL. Moreover, the UIC and retinol levels were significantly different in each province (P < 0.05).
Table 2. Characteristics of Chinese mothers from three different regions
Characteristics Hebei (n = 493) Zhejiang (n = 429) Guangxi (n = 389) Total (n = 1,311) Rural, n (%) 289 (60.45) 244 (56.88) 172 (44.22)* 714 (54.46) Parity, n (%) 1 185 (37.53) 170 (39.63) 119 (30.59) 474 (36.16) 2 293 (59.43) 247 (57.58) 239 (61.44) 779 (59.42) ≥ 3 15 (3.04) 12 (2.79) 31 (7.97) 58 (4.42) In lactation, n (%) Yes 382 (77.48) 262 (61.07) 252 (64.78) 896 (68.34) No 111 (22.52) 167 (38.93) 137 (35.22) 415 (31.66) Age (years) 30.00 (27.00–33.00) 31.07 (28.19–35.94) * 30.25 (26.99–33.84) 30.04 (27.15–34.23) BMI (kg/m2) 23.82 (21.61–26.31) * 22.29 (20.44–24.92) 22.03 (20.17–24.51) 22.78 (20.65–25.41) UIC (μg/L) 166.10 (116.30–228.60) * 123.58 (86.53–184.42) * 139.40 (90.90–205.20) * 142.00 (99.10–209.40) TSH (mIU/L) 2.11 (1.48–2.87) * 1.72 (1.21–2.34) 1.86 (1.24–2.50) 1.89 (1.32–2.59) Retinol (μg/mL) 0.43 (0.37–0.54) * 0.36 (0.30–0.45) * 0.51 (0.44–0.59) * 0.44 (0.36–0.53) 25(OH)D (ng/mL) 17.20 (13.70–21.82) * 28.26 (23.39–34.14) 26.40 (23.40–30.20) 24.04 (18.20–29.00) Note. BMI: body mass index, UIC: urinary iodine concentration, TSH: thyroid-stimulating hormone, 25(OH)D: 25-hydroxyvitamin D. *Compared to the other two provinces, P < 0.05. Data were represented as n (%) or median (P25−P75). -
As shown in Table 3, the MUICs of total mothers, mothers in lactation, and mothers not in lactation were 142.00 (95% CI: 40.74−358.97) μg/L, 139.95 (95% CI: 41.47−350.42) μg/L, and 148.69 (95% CI: 35.10−382.08) μg/L, respectively. No significant differences in UIC were found between breastfeeding and non-breastfeeding mothers. The proportion of UIC values < 50 μg/L was 5.03%. Mothers from the three provinces had no iodine deficiency. Zhejiang had the lowest UIC and highest rate of < 50 μg/L (123.58 μg/L and 6.99%, respectively), while Hebei was in the opposite. The MUIC in rural areas was higher than that in urban areas (P < 0.05). As differences in the proportions of urban and rural populations existed among the three provinces, we further analyzed whether the relationship between region and UIC was affected by area type using a two-way ANOVA model. The results showed an interaction effect between region and area type (data not shown). There was no significant difference in UIC among different age groups (P > 0.05), but the highest rate of UIC < 50 μg/L was found in the 18−< 25 years group. MUIC was highest among obese mothers (P < 0.05). There was no significant difference in the UIC among the different VA subgroups (P > 0.05); however, the UIC seemed to be lower in the VA deficiency group than that in the other two groups. In contrast, MUIC was highest in the VD deficiency group (P < 0.05).
Table 3. Distributions of UIC among Chinese mothers
Factors N (%) MUIC (95% CI), μg/L UIC < 50 μg/L, N (%) Region Hebei 493 (37.61) 166.10 (48.88−336.18)a, b 13 (2.64) Zhejiang 429 (32.72) 123.58 (32.41−399.95)c 30 (6.99) Guangxi 389 (29.67) 139.40 (39.48−419.55) 23 (5.91) Area type Rural 714 (54.46) 159.80 (46.54−377.42)d 23 (3.22) Urban 597 (45.54) 125.30 (34.03−342.88) 43 (7.20) Parity 1 474 (36.16) 138.95 (34.65−359.11) 30 (6.33) 2 779 (59.42) 143.54 (43.40−365.55) 33 (4.24) ≥ 3 58 (4.42) 146.75 (32.26−358.34) 3 (5.17) In lactation Yes 896 (68.34) 139.95 (41.47−350.42) 46 (5.13) No 415 (31.66) 148.69 (35.10−382.08) 20 (4.82) Age (years) 18− 129 (9.84) 142.00 (33.28−411.05) 14 (10.85) 25− 883 (67.35) 146.00 (38.32−355.14) 45 (5.10) ≥ 35 299 (22.81) 136.13 (49.69−368.02) 7 (2.34) BMI Underweight 89 (6.79) 152.14 (34.78−478.78) 6 (6.74) Normal weight 725 (55.30) 140.90 (37.56−405.25) 39 (5.38) Overweight 335 (25.55) 131.30 (44.37−355.34) 14 (4.18) Obesity 162 (12.36) 169.55 (43.22−335.92)e 7 (4.32) TSH (mIU/L) < 0.27 30 (2.29) 178.65 (75.13−303.35) 0 (0.00) 0.27−4.20 1197 (91.30) 141.16 (39.34−369.92) 65 (5.43) > 4.20 84 (6.41) 160.57 (51.44−287.15) 1 (1.19) VA Deficiency 17 (1.30) 119.34 (66.98−249.44) 0 (0.00) Marginal deficiency 129 (9.84) 140.02 (30.60−497.44) 8 (6.20) Sufficiency 1165 (88.86) 142.40 (40.88−355.12) 58 (4.98) VD Deficiency 78 (5.95) 175.10 (41.48−341.40)f 2 (2.56) Insufficiency 340 (25.93) 159.30 (42.22−329.64)g 16 (4.71) Sufficiency 893 (68.12) 133.86 (37.49−389.36) 48 (5.37) Total 1311 (100.00) 142.00(40.74−358.97) 66 (5.03) Note. MUIC: median urinary iodine concentration, BMI: body mass index, VA: vitamin A, VD: vitamin D. a: Hebei vs. Zhejiang; b: Hebei vs. Guangxi; c: Zhejiang vs. Guangxi; d: Rural vs. Urban; e: Overweight vs. Obesity; f: Deficiency vs. Sufficiency; g: Insufficiency vs. Sufficiency. Statistical significance was set at P < 0.05. -
Table 4 shows that the median TSH levels of the mothers were within the reference range and the overall TSH exceedance rate was only 6.41%. There were no significant differences in TSH levels among the different area types, parity, lactation, age, and VA or UIC groups (P > 0.05). The TSH level was the highest in Hebei (median: 2.11 mIU/L). In addition, we found that BMI was associated with the distribution of TSH, and overweight and obese mothers had the highest rates of subclinical hypothyroidism or hypothyroidism (P < 0.05). Moreover, TSH levels in the VD deficiency and insufficiency groups were higher than those in the sufficiency group (P < 0.05). However, no U-shaped relationship was observed between TSH levels and UIC.
Table 4. TSH concentrations and distributions among mothers in the three provinces
Factors N Median (P25–P75), mIU/L Frequency Distribution (%) Per TSH Range, mIU/L < 0.27 0.27–< 4.20 ≥ 4.20 P Region 0.072 Hebei 493 (37.61) 2.11(1.48−2.87)a, b 13 (2.64) 437 (88.64) 43 (8.72) Zhejiang 429 (32.72) 1.72 (1.21−2.34) 11 (2.56) 397 (92.54) 21 (4.90) Guangxi 389 (29.67) 1.86 (1.24−2.50) 6 (1.54) 363 (93.32) 20 (5.14) Area type 0.053 Rural 714 (54.46) 1.89 (1.32−2.66) 18 (2.52) 640 (89.64) 56 (7.84) Urban 597(45.54) 1.89( 1.32−2.58) 12 (2.01) 557 (93.30) 28 (4.69) Parity (%) 0.612 1 474 (36.16) 1.92 (1.33−2.68) 10 (2.11) 430 (90.72) 34 (7.17) 2 779 (59.42) 1.87 (1.30−2.54) 19 (2.44) 716 (91.91) 44 (5.65) ≥ 3 58 (4.42) 1.96 (1.47−2.82) 1 (1.72) 51 (87.93) 6 (10.34) In lactation 0.449 Yes 896 (68.34) 1.88 (1.34−2.59) 23 (2.57) 819 (91.41) 54 (6.03) No 415 (31.66) 1.90 (1.29−2.66) 7 (1.69) 378 (91.08) 30 (7.23) Age (years) 0.910 18 to < 25 129 (9.84) 1.88 (1.30−2.66) 3 (2.33) 117 (90.70) 9 (6.98) 25 to < 35 883 (67.35) 1.86 (1.31−2.59) 19 (2.15) 805 (91.17) 59 (6.68) ≥ 35 299 (22.81) 1.96 (1.41−2.59) 8 (2.68) 275 (91.97) 16 (5.35) BMI 0.001 Underweight 89 (6.79) 2.07 (1.31−2.72) 0 (0.00) 88 (98.88)# 1 (1.12) Normal weight 725 (55.30) 1.86 (1.32−2.53) 16 (2.21) 672 (92.69) 37 (5.10) Overweight 335 (25.55) 1.92 (1.31−2.77) 12 (3.58) 292 (87.16) 31 (9.25)# Obesity 162 (12.36) 1.98 (1.27−2.66) 2 (1.23) 145 (89.51) 15 (9.26)# VA 0.073 Deficiency 17 (1.30) 1.57 (1.18−2.42) 1 (5.88) 16 (94.12) 0 (0.00) Marginal deficiency 129 (9.84) 1.71 (1.24−2.46) 2 (1.55) 124 (96.12) 3 (2.33) Sufficiency 1,165 (88.86) 1.91 (1.34−2.65) 27 (2.32) 1,057 (90.73) 81 (6.95) VD 0.580 Deficiency 78 (5.95) 2.14 (1.50−2.88)c 1 (1.28) 72 (92.31) 5 (6.41) Insufficiency 340 (25.93) 2.09 (1.47−2.81)d 6 (1.76) 307 (90.29) 27 (7.94) Sufficiency 893 (68.12) 1.80 (1.26−2.50) 23 (2.58) 818 (91.60) 52 (5.82) UIC (μg/L) 0.324 < 100 332 (25.32) 1.80 (1.31−2.36) 7 (2.11) 309 (93.07) 16 (4.82) 100 to < 150 366 (27.92) 1.81 (1.26−2.56) 5 (1.39) 338 (92.35) 23 (6.28) 150 to < 200 252 (19.22) 1.94 (1.44−2.73) 7 (2.78) 224 (88.89) 21 (8.33) 200 to < 250 176 (13.42) 2.04 (1.36−2.86) 7 (3.98) 154 (87.50) 15 (8.52) ≥ 250 185 (14.11) 2.05 (1.34−2.75) 4 (2.16) 172 (92.97) 9 (4.86) Total 1,311 (100.00) 1.89 (1.32−2.59) 30 (2.29) 1,197 (91.30) 84 (6.41) Note. UIC: urinary iodine concentration, TSH: thyroid−stimulating hormone, BMI: body mass index, VA: vitamin A, VD: vitamin Da: Hebei vs. Zhejiang; b: Hebei vs. Guangxi; c,: Deficiency vs. Sufficiency; d: Insufficiency vs. Sufficiency; #: group differences. Statistical significance was set at P < 0.05. -
The generalized linear model analysis showed that UIC was marginally positively correlated with total VA (β = 28.713, P = 0.053), but negatively correlated with total VD (β = −0.930, P = 0.002). After adjusting for variables including region, area type, parity, lactation, age, and BMI, UIC was not correlated with total VA (β = 26.977, P = 0.095) or total VD (β = −0.032, P = 0.930). Generalized linear model analysis also indicated that UIC was not correlated with the nutritional status of VA after stratification, with or without adjustment for covariates (P > 0.05). UICs in the VD insufficient group and deficient group were higher than that in sufficient group (βinsufficiency = 15.503, P = 0.005; βdeficiency = 26.999, P = 0.008) when the covariates were not adjusted. After adjusting for covariates, the UIC was no longer associated with the VD nutritional status (P > 0.05) (Table 5).
Table 5. Association between UIC and VA/VD nutritional status
Factors UIC β (95% CI) SE P VA-Model 1 Total 28.713 (−0.418 to 57.843) 14.863 0.053 Deficiency −21.243 (−62.504 to 20.018) 21.052 0.313 Marginal deficiency 1.949 (−13.723 to 17.621) 7.996 0.807 Sufficiency 0 VA-Model 2 Total 26.977 (−4.730 to 58.683) 16.177 0.095 Deficiency −10.681 (−51.768 to 30.407) 20.963 0.610 Marginal deficiency 4.998 (−11.104 to 21.100) 8.215 0.543 Sufficiency 0 VD-Model 1 Total −0.930 (−1.505 to −0.355) 0.294 0.002 Deficiency 26.999 (7.149 to 46.849) 10.128 0.008 Insufficiency 15.503 (4.789 to 26.216) 5.466 0.005 Sufficiency 0 VD-Model 2 Total 0.032 (−0.685 to 0.750) 0.366 0.930 Deficiency 8.392 (−13.081 to 29.864) 10.956 0.444 Insufficiency 1.747 (−10.761 to 14.255) 6.382 0.784 Sufficiency 0 Note. UIC: urinary iodine concentration, VA: vitamin A, VD: vitamin D. Model 1: unadjusted;Model 2: adjusted for region, area type, parity, lactating or not, age, and BMI. Statistical significance was set at P < 0.05. The same methods listed in Table 5 were used to analyze the linear relationship between TSH and iodine, VA, and VD nutritional status. The results showed that TSH levels did not correlate with the UIC, VA, or VD concentrations (P > 0.05). The nutritional status of iodine, VA, and VD was not related to TSH with or without adjustment for confounders (P > 0.05) (data not shown).
-
We analyzed the relationship between UIC and TSH under different vitamin A/D nutritional conditions, which could further describe the interactive effects of VA or VD status and iodine status on TSH levels and abnormalities. The median TSH level in each group was within the normal range. Participants with higher UIC and VD deficiencies also had higher TSH levels, although the difference was not statistically significant. No statistically significant VD-iodine interactive effects on TSH abnormalities were observed (Figure 1B and 1D). Moreover, no interactions between VA and iodine contributed to TSH levels or abnormalities (P > 0.05) (Figure 1A and 1C).
doi: 10.3967/bes2024.029
Iodine Nutrition, Thyroid-stimulating Hormone, and Related Factors of Postpartum Women from three Different Areas in China: A Cross-sectional Survey
-
Abstract:
Objective Studies on the relationship between iodine, vitamin A (VA), and vitamin D (VD) and thyroid function are limited. This study aimed to analyze iodine and thyroid-stimulating hormone (TSH) status and their possible relationships with VA, VD, and other factors in postpartum women. Methods A total of 1,311 mothers (896 lactating and 415 non-lactating) from Hebei, Zhejiang, and Guangxi provinces were included in this study. The urinary iodine concentration (UIC), TSH, VA, and VD were measured. Results The median UIC of total and lactating participants were 142.00 µg/L and 139.95 µg/L, respectively. The median TSH, VA, and VD levels in all the participants were 1.89 mIU/L, 0.44 μg/mL, and 24.04 ng/mL, respectively. No differences in the UIC were found between lactating and non-lactating mothers. UIC and TSH levels were significantly different among the three provinces. The rural UIC was higher than the urban UIC. Obese mothers had a higher UIC and a higher prevalence of excessive TSH. Higher UICs and TSHs levels were observed in both the VD deficiency and insufficiency groups than in the VD-sufficient group. After adjustment, no linear correlation was observed between UIC and VA/VD. No interaction was found between vitamins A/D and UIC on TSH levels. Conclusion The mothers in the present study had no iodine deficiency. Region, area type, BMI, and VD may be related to the iodine status or TSH levels. -
Key words:
- Median urinary iodine concentration /
- Thyroid-stimulating hormone /
- Vitamin A /
- Vitamin D /
- Postpartum women
The authors declare that they have no conflict of interest.
注释:1) AUTHOR STATEMENT: 2) DECLARATION OF INTERESTS: -
Table 1. Reference range of related parameters
Parameter Reference range Identification BMI (kg/m2)[19,20] < 18.5
18.5 to < 24
24.0 to < 28
≥ 28Underweight
Normal weight
Overweight
ObeseMUIC (μg/L)[21,22] 100−299 and proportion of < 50 was ≤ 20% Adequate iodine intake TSH (mIU/L, Roche Kit) < 0.27 Subclinical hyperthyroidism or hyperthyroidism 0.27 to < 4.20 Normal ≥ 4.20 Subclinical hypothyroidism or hypothyroidism VA (µg/mL) < 0.2
0.2 to < 0.3
≥ 0.3Deficiency
Marginal deficiency
SufficiencyVD (nmol/L) < 30
30 to < 50
≥ 50Deficiency
Insufficiency
SufficiencyNote. MUIC: median urinary iodine concentration, TSH: thyroid-stimulating hormone, BMI: body mass index, VA: vitamin A, VD: vitamin D. Table 2. Characteristics of Chinese mothers from three different regions
Characteristics Hebei (n = 493) Zhejiang (n = 429) Guangxi (n = 389) Total (n = 1,311) Rural, n (%) 289 (60.45) 244 (56.88) 172 (44.22)* 714 (54.46) Parity, n (%) 1 185 (37.53) 170 (39.63) 119 (30.59) 474 (36.16) 2 293 (59.43) 247 (57.58) 239 (61.44) 779 (59.42) ≥ 3 15 (3.04) 12 (2.79) 31 (7.97) 58 (4.42) In lactation, n (%) Yes 382 (77.48) 262 (61.07) 252 (64.78) 896 (68.34) No 111 (22.52) 167 (38.93) 137 (35.22) 415 (31.66) Age (years) 30.00 (27.00–33.00) 31.07 (28.19–35.94) * 30.25 (26.99–33.84) 30.04 (27.15–34.23) BMI (kg/m2) 23.82 (21.61–26.31) * 22.29 (20.44–24.92) 22.03 (20.17–24.51) 22.78 (20.65–25.41) UIC (μg/L) 166.10 (116.30–228.60) * 123.58 (86.53–184.42) * 139.40 (90.90–205.20) * 142.00 (99.10–209.40) TSH (mIU/L) 2.11 (1.48–2.87) * 1.72 (1.21–2.34) 1.86 (1.24–2.50) 1.89 (1.32–2.59) Retinol (μg/mL) 0.43 (0.37–0.54) * 0.36 (0.30–0.45) * 0.51 (0.44–0.59) * 0.44 (0.36–0.53) 25(OH)D (ng/mL) 17.20 (13.70–21.82) * 28.26 (23.39–34.14) 26.40 (23.40–30.20) 24.04 (18.20–29.00) Note. BMI: body mass index, UIC: urinary iodine concentration, TSH: thyroid-stimulating hormone, 25(OH)D: 25-hydroxyvitamin D. *Compared to the other two provinces, P < 0.05. Data were represented as n (%) or median (P25−P75). Table 3. Distributions of UIC among Chinese mothers
Factors N (%) MUIC (95% CI), μg/L UIC < 50 μg/L, N (%) Region Hebei 493 (37.61) 166.10 (48.88−336.18)a, b 13 (2.64) Zhejiang 429 (32.72) 123.58 (32.41−399.95)c 30 (6.99) Guangxi 389 (29.67) 139.40 (39.48−419.55) 23 (5.91) Area type Rural 714 (54.46) 159.80 (46.54−377.42)d 23 (3.22) Urban 597 (45.54) 125.30 (34.03−342.88) 43 (7.20) Parity 1 474 (36.16) 138.95 (34.65−359.11) 30 (6.33) 2 779 (59.42) 143.54 (43.40−365.55) 33 (4.24) ≥ 3 58 (4.42) 146.75 (32.26−358.34) 3 (5.17) In lactation Yes 896 (68.34) 139.95 (41.47−350.42) 46 (5.13) No 415 (31.66) 148.69 (35.10−382.08) 20 (4.82) Age (years) 18− 129 (9.84) 142.00 (33.28−411.05) 14 (10.85) 25− 883 (67.35) 146.00 (38.32−355.14) 45 (5.10) ≥ 35 299 (22.81) 136.13 (49.69−368.02) 7 (2.34) BMI Underweight 89 (6.79) 152.14 (34.78−478.78) 6 (6.74) Normal weight 725 (55.30) 140.90 (37.56−405.25) 39 (5.38) Overweight 335 (25.55) 131.30 (44.37−355.34) 14 (4.18) Obesity 162 (12.36) 169.55 (43.22−335.92)e 7 (4.32) TSH (mIU/L) < 0.27 30 (2.29) 178.65 (75.13−303.35) 0 (0.00) 0.27−4.20 1197 (91.30) 141.16 (39.34−369.92) 65 (5.43) > 4.20 84 (6.41) 160.57 (51.44−287.15) 1 (1.19) VA Deficiency 17 (1.30) 119.34 (66.98−249.44) 0 (0.00) Marginal deficiency 129 (9.84) 140.02 (30.60−497.44) 8 (6.20) Sufficiency 1165 (88.86) 142.40 (40.88−355.12) 58 (4.98) VD Deficiency 78 (5.95) 175.10 (41.48−341.40)f 2 (2.56) Insufficiency 340 (25.93) 159.30 (42.22−329.64)g 16 (4.71) Sufficiency 893 (68.12) 133.86 (37.49−389.36) 48 (5.37) Total 1311 (100.00) 142.00(40.74−358.97) 66 (5.03) Note. MUIC: median urinary iodine concentration, BMI: body mass index, VA: vitamin A, VD: vitamin D. a: Hebei vs. Zhejiang; b: Hebei vs. Guangxi; c: Zhejiang vs. Guangxi; d: Rural vs. Urban; e: Overweight vs. Obesity; f: Deficiency vs. Sufficiency; g: Insufficiency vs. Sufficiency. Statistical significance was set at P < 0.05. Table 4. TSH concentrations and distributions among mothers in the three provinces
Factors N Median (P25–P75), mIU/L Frequency Distribution (%) Per TSH Range, mIU/L < 0.27 0.27–< 4.20 ≥ 4.20 P Region 0.072 Hebei 493 (37.61) 2.11(1.48−2.87)a, b 13 (2.64) 437 (88.64) 43 (8.72) Zhejiang 429 (32.72) 1.72 (1.21−2.34) 11 (2.56) 397 (92.54) 21 (4.90) Guangxi 389 (29.67) 1.86 (1.24−2.50) 6 (1.54) 363 (93.32) 20 (5.14) Area type 0.053 Rural 714 (54.46) 1.89 (1.32−2.66) 18 (2.52) 640 (89.64) 56 (7.84) Urban 597(45.54) 1.89( 1.32−2.58) 12 (2.01) 557 (93.30) 28 (4.69) Parity (%) 0.612 1 474 (36.16) 1.92 (1.33−2.68) 10 (2.11) 430 (90.72) 34 (7.17) 2 779 (59.42) 1.87 (1.30−2.54) 19 (2.44) 716 (91.91) 44 (5.65) ≥ 3 58 (4.42) 1.96 (1.47−2.82) 1 (1.72) 51 (87.93) 6 (10.34) In lactation 0.449 Yes 896 (68.34) 1.88 (1.34−2.59) 23 (2.57) 819 (91.41) 54 (6.03) No 415 (31.66) 1.90 (1.29−2.66) 7 (1.69) 378 (91.08) 30 (7.23) Age (years) 0.910 18 to < 25 129 (9.84) 1.88 (1.30−2.66) 3 (2.33) 117 (90.70) 9 (6.98) 25 to < 35 883 (67.35) 1.86 (1.31−2.59) 19 (2.15) 805 (91.17) 59 (6.68) ≥ 35 299 (22.81) 1.96 (1.41−2.59) 8 (2.68) 275 (91.97) 16 (5.35) BMI 0.001 Underweight 89 (6.79) 2.07 (1.31−2.72) 0 (0.00) 88 (98.88)# 1 (1.12) Normal weight 725 (55.30) 1.86 (1.32−2.53) 16 (2.21) 672 (92.69) 37 (5.10) Overweight 335 (25.55) 1.92 (1.31−2.77) 12 (3.58) 292 (87.16) 31 (9.25)# Obesity 162 (12.36) 1.98 (1.27−2.66) 2 (1.23) 145 (89.51) 15 (9.26)# VA 0.073 Deficiency 17 (1.30) 1.57 (1.18−2.42) 1 (5.88) 16 (94.12) 0 (0.00) Marginal deficiency 129 (9.84) 1.71 (1.24−2.46) 2 (1.55) 124 (96.12) 3 (2.33) Sufficiency 1,165 (88.86) 1.91 (1.34−2.65) 27 (2.32) 1,057 (90.73) 81 (6.95) VD 0.580 Deficiency 78 (5.95) 2.14 (1.50−2.88)c 1 (1.28) 72 (92.31) 5 (6.41) Insufficiency 340 (25.93) 2.09 (1.47−2.81)d 6 (1.76) 307 (90.29) 27 (7.94) Sufficiency 893 (68.12) 1.80 (1.26−2.50) 23 (2.58) 818 (91.60) 52 (5.82) UIC (μg/L) 0.324 < 100 332 (25.32) 1.80 (1.31−2.36) 7 (2.11) 309 (93.07) 16 (4.82) 100 to < 150 366 (27.92) 1.81 (1.26−2.56) 5 (1.39) 338 (92.35) 23 (6.28) 150 to < 200 252 (19.22) 1.94 (1.44−2.73) 7 (2.78) 224 (88.89) 21 (8.33) 200 to < 250 176 (13.42) 2.04 (1.36−2.86) 7 (3.98) 154 (87.50) 15 (8.52) ≥ 250 185 (14.11) 2.05 (1.34−2.75) 4 (2.16) 172 (92.97) 9 (4.86) Total 1,311 (100.00) 1.89 (1.32−2.59) 30 (2.29) 1,197 (91.30) 84 (6.41) Note. UIC: urinary iodine concentration, TSH: thyroid−stimulating hormone, BMI: body mass index, VA: vitamin A, VD: vitamin Da: Hebei vs. Zhejiang; b: Hebei vs. Guangxi; c,: Deficiency vs. Sufficiency; d: Insufficiency vs. Sufficiency; #: group differences. Statistical significance was set at P < 0.05. Table 5. Association between UIC and VA/VD nutritional status
Factors UIC β (95% CI) SE P VA-Model 1 Total 28.713 (−0.418 to 57.843) 14.863 0.053 Deficiency −21.243 (−62.504 to 20.018) 21.052 0.313 Marginal deficiency 1.949 (−13.723 to 17.621) 7.996 0.807 Sufficiency 0 VA-Model 2 Total 26.977 (−4.730 to 58.683) 16.177 0.095 Deficiency −10.681 (−51.768 to 30.407) 20.963 0.610 Marginal deficiency 4.998 (−11.104 to 21.100) 8.215 0.543 Sufficiency 0 VD-Model 1 Total −0.930 (−1.505 to −0.355) 0.294 0.002 Deficiency 26.999 (7.149 to 46.849) 10.128 0.008 Insufficiency 15.503 (4.789 to 26.216) 5.466 0.005 Sufficiency 0 VD-Model 2 Total 0.032 (−0.685 to 0.750) 0.366 0.930 Deficiency 8.392 (−13.081 to 29.864) 10.956 0.444 Insufficiency 1.747 (−10.761 to 14.255) 6.382 0.784 Sufficiency 0 Note. UIC: urinary iodine concentration, VA: vitamin A, VD: vitamin D. Model 1: unadjusted;Model 2: adjusted for region, area type, parity, lactating or not, age, and BMI. Statistical significance was set at P < 0.05. -
[1] Zimmermann MB. The role of iodine in human growth and development. Semin Cell Dev Biol, 2011; 22, 645−52. doi: 10.1016/j.semcdb.2011.07.009 [2] Aakre I, Bjoro T, Norheim I, et al. Excessive iodine intake and thyroid dysfunction among lactating Saharawi women. J Trace Elem Med Biol, 2015; 31, 279−84. doi: 10.1016/j.jtemb.2014.09.009 [3] Sun DJ, Lei ZL, Liu SJ. China national iodine deficiency disorders surveillance report 2014. The People's Medical Publishing House, 2017. (In Chinese [4] Cui SL, Liu P, Su XH, et al. Surveys in areas of high risk of iodine deficiency and iodine excess in China, 2012-2014: current status and examination of the relationship between urinary iodine concentration and goiter prevalence in children aged 8-10 years. Biomed Environ Sci, 2017; 30, 88−96. [5] Shan XY, Liu CQ, Luo XY, et al. Iodine nutritional status and related factors among Chinese school-age children in three different areas: a cross-sectional study. Nutrients, 2021; 13, 1404. doi: 10.3390/nu13051404 [6] Liao M, Liu J, Ning RJ, et al. Investigation of iodine nutrition status and thyroid function of lactating women in Guangxi. Acta Nutr Sin, 2020; 42, 99−101. (In Chinese [7] Ding Y, Indayati W, Basnet TB, et al. Dietary intake in lactating mothers in China 2018: report of a survey. Nutr J, 2020; 19, 72. doi: 10.1186/s12937-020-00589-x [8] WHO. Breastfeeding: recommendations.https://www.who.int/health-topics/breastfeeding#tab=tab_2. [2023-08-09]. [9] Pinkaew S, Udomkesmalee E, Davis CR, et al. Vitamin A-fortified rice increases total body vitamin A stores in lactating Thai women measured by retinol isotope dilution: a double-blind, randomized, controlled trial. Am J Clin Nutr, 2021; 113, 1372−80. doi: 10.1093/ajcn/nqaa418 [10] Roth DE, Abrams SA, Aloia J, et al. Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low- and middle-income countries. Ann N Y Acad Sci, 2018; 1430, 44−79. doi: 10.1111/nyas.13968 [11] Zimmermann N. Interactions of vitamin a and iodine deficiencies: effects on the pituitary-thyroid axis. Int J Vitam Nutr Res, 2007; 77, 236−40. doi: 10.1024/0300-9831.77.3.236 [12] Kim D. The role of vitamin D in thyroid diseases. Int J Mol Sci, 2017; 18, 1949. doi: 10.3390/ijms18091949 [13] Kim M, Song EY, Oh HS, et al. Vitamin D deficiency affects thyroid autoimmunity and dysfunction in iodine-replete area: Korea national health and nutrition examination survey. Endocrine, 2017; 58, 332−9. doi: 10.1007/s12020-017-1425-z [14] Guo YP, Zhang LW, Miao K, et al. Correlation of thyroid structure and iodine nutrition status with sex and age in adults. Chin J Ultrasound Med, 2020; 36, 588−91. (In Chinese [15] Banach W, Nitschke K, Krajewska N, et al. The association between excess body mass and disturbances in somatic mineral levels. Int J Mol Sci, 2020; 21, 7306. doi: 10.3390/ijms21197306 [16] Dold S, Zimmermann MB, Jukic T, et al. Universal salt iodization provides sufficient dietary iodine to achieve adequate iodine nutrition during the first 1000 days: a cross-sectional multicenter study. J Nutr, 2018; 148, 587−98. doi: 10.1093/jn/nxy015 [17] Lu ZB. Comparison of lactating women vitamin levels and folic acid level in urban and rural areas of Nanjing. Lab Med Clin, 2020; 17, 1480−82,1486. (In Chinese [18] Jiang S, Wang J, Duan YF, et al. Prevalence and risk factors for anemia of Chinese lactating women in 2013. J Hyg Res, 2021; 50, 716−21. [19] Fang HY, Guo QY, Ju LH, Li SJ, Xu XL, Piao W, Yu DM, Zhao LY. Weight Status and Self-Perception of Weight Among Women of Childbearing Age - China, 2015. China CDC Wkly, 2021; 3: 185−8. [20] WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 2004; 363, 157−63. doi: 10.1016/S0140-6736(03)15268-3 [21] UNICEF, Iodine Global Network. Guidance on the monitoring of salt iodization programmes and determination of population iodine status: Russian language version. Clin Exp Thyroidol, 2018; 14, 100-12. [22] WHO. Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers. 3rd ed. WHO. 2007. [23] Haddow JE, McClain MR, Palomaki GE, et al. Urine iodine measurements, creatinine adjustment, and thyroid deficiency in an adult United States population. J Clin Endocrinol Metab, 2007; 92, 1019−22. doi: 10.1210/jc.2006-2156 [24] Xiu LL, Zhong GS, Ma XM. Urinary iodine concentration (UIC) could be a promising biomarker for predicting goiter among school-age children: a systematic review and meta-analysis. PLoS One, 2017; 12, e0174095. doi: 10.1371/journal.pone.0174095 [25] Pearce EN, Caldwell KL. Urinary iodine, thyroid function, and thyroglobulin as biomarkers of iodine status. Am J Clin Nutr, 2016; 104 Suppl 3, 898S-901S. [26] Yang LC, Li M, Liu XB, et al. Evaluation of iodine nutritional status among pregnant women in China. Thyroid, 2020; 30, 443−50. doi: 10.1089/thy.2019.0001 [27] Nazeri P, Mirmiran P, Shiva N, et al. Iodine nutrition status in lactating mothers residing in countries with mandatory and voluntary iodine fortification programs: an updated systematic review. Thyroid, 2015; 25, 611−20. doi: 10.1089/thy.2014.0491 [28] Liu LX, Liu JW, Wang DD, et al. Effect of urinary iodine concentration in pregnant and lactating women, and in their infants residing in areas with excessive iodine in drinking water in Shanxi Province, China. Biol Trace Elem Res, 2020; 193, 326−33. doi: 10.1007/s12011-019-01716-4 [29] Wang DD, Wan SY, Liu P, et al. Relationship between excess iodine, thyroid function, blood pressure, and blood glucose level in adults, pregnant women, and lactating women: a cross-sectional study. Ecotoxicol Environ Saf, 2021; 208, 111706. doi: 10.1016/j.ecoenv.2020.111706 [30] Lou XM, Wang XF, Mao GM, et al. Geographical influences on the iodine status in pregnant women, neonates, and school-age children in China. Nutr J, 2020; 19, 7. doi: 10.1186/s12937-020-0525-4 [31] Mo Z, Zhu WM, Lou XM, et al. Surveys on iodine level in population of Zhejiang in 2011. Chin Prev Med, 2012; 13, 828−32. (In Chinese [32] Lü SM, Ma J, Du YG, et al. Analysis of iodine deficiency disorders surveillance results in Hebei Province in 2011. Chin J Endemiol, 2013; 32, 281−3. (In Chinese [33] Mao GM, Ding GQ, Huang LC, et al. Study on level of dietary iodine intake and its contribution rate of residents in Zhejiang. Chin J Prev Med, 2013; 47, 1031−5. [34] Zou Y, Lou XM, Ding GQ, et al. A cross-sectional comparison study on the iodine nutritional status between rural and urban residents in Zhejiang Province, China. BMJ Open, 2014; 4, e005484. doi: 10.1136/bmjopen-2014-005484 [35] Huang CJ, Cheng CP, Lee LH, et al. Iodine nutritional status of lactating women in northern Taiwan in 2019. J Chin Med Assoc, 2021; 84, 400−4. doi: 10.1097/JCMA.0000000000000505 [36] Bocco BMLC, Fernandes GW, Fonseca TL, et al. Iodine deficiency increases fat contribution to energy expenditure in male mice. Endocrinology, 2020; 161, bqaa192. doi: 10.1210/endocr/bqaa192 [37] García-Solís P, Solís-S JC, García-Gaytán AC, et al. Iodine nutrition in elementary state schools of Queretaro, Mexico: correlations between urinary iodine concentration with global nutrition status and social gap index. Arq Bras Endocrinol Metabol, 2013; 57, 473−82. doi: 10.1590/S0004-27302013000600010 [38] Jouanne M, Oddoux S, Noël A, et al. Nutrient requirements during pregnancy and lactation. Nutrients, 2021; 13, 692. doi: 10.3390/nu13020692 [39] Dong CX, Yin SA. The nutrition status of lactating women in China. Chin J Prev Med, 2016; 50, 1108−13. (In Chinese [40] Wang J. Monitoring report on nutrition and health status of Chinese residents (2010-2013): nutrition and health status of pregnant women and lactating mothers in China. People's Health Publishing House. 2020. (In Chinese [41] Pang XH, Yang ZY, Wang J, et al. Nutritional status and influence of vitamin D among Chinese lactating women in 2013. Chin J Prev Med, 2016; 50, 1056−60. (In Chinese [42] Okosieme O, Gilbert J, Abraham P, et al. Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee. Clin Endocrinol (Oxf), 2016; 84, 799−808. doi: 10.1111/cen.12824 [43] Ceresini G, Rebecchi I, Morganti S, et al. Effects of vitamin A administration on serum thyrotropin concentrations in healthy human subjects. Metabolism, 2002; 51, 691−4. doi: 10.1053/meta.2002.32724 [44] De Remigis A, Tomei G, Maria Lattanzio F, et al. Inverse relationship between seasonal vitamin D variations and thyroid antibodies (TAb) and TSH. Endocr Abstr, 2016; 41, EP972. [45] Meng FG, Zhao RC, Liu P, et al. Assessment of iodine status in children, adults, pregnant women and lactating women in iodine-replete areas of China. PLoS One, 2013; 8, e81294. doi: 10.1371/journal.pone.0081294 [46] Liu LX, Wang DD, Liu P, et al. The relationship between iodine nutrition and thyroid disease in lactating women with different iodine intakes. Br J Nutr, 2015; 114, 1487−95. doi: 10.1017/S0007114515003128